Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
about
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trialRenal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitorsTrends in hospitalizations among children and young adults with perinatally acquired HIV.Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimensExpert opinion on pharmacotherapy of kidney disease in HIV-infected patients.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infectionAdvances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.Renal disease in HIV-infected individualsVitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.Urinary biomarkers of kidney diseases in HIV-infected children.Kidney disease in children and adolescents with perinatal HIV-1 infection.Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIVTenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Chronic hepatitis B virus infection and pregnancy.Pediatric antiretroviral therapy.Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection.Update on tenofovir toxicity in the kidney.Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study.Respiratory Syncytial Virus in Children with Influenza-like Illness.Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study.Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years.Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study.
P2860
Q28483723-5471913F-8D53-4166-900C-F728423229E0Q34136166-8D6B000E-392D-422F-ABD5-070F9ABA15BBQ34432664-F87921A3-E389-49F6-8114-E30E79821F60Q34488494-85D9D80E-619B-4AA7-A75E-71045A61D0BDQ34686870-C0BE2430-FD14-4A01-A1B7-9999F6B8C29EQ34736194-BF9EAACC-30A3-4F45-BFE6-B170B8736236Q35091365-7DB250CD-5EA2-480A-AACB-8FD5967A0A5DQ35596237-6ED3F932-79C5-412D-A1BF-D4FE2F9B8B37Q35698442-62DC148D-B6F8-4F22-896F-7508525F02C8Q35815286-EEC351B8-63CC-4646-BB38-C0D9BD8809A3Q35934081-71074BC4-EF49-415A-AD83-582CA29AC49EQ36942310-A2741893-ADB9-45AC-AADC-52FE73C279E3Q37077047-2EADD95E-C936-4E2D-9BE7-575BF264822CQ37238911-4CEF9102-CE5C-4D8D-B2CF-4C30EE8BBD1EQ37263395-ADCBDD78-8004-489E-AE76-540CC5E9844CQ37613468-E4E76CC6-2B5D-46C6-827C-D6233A44B6F1Q37816389-7970C6BE-4497-41E8-8E5D-CD04D9511609Q37816391-2948019F-C4B5-4537-A4F9-7E50558CD156Q38033446-E0AC44F6-534A-4F7C-9328-6354E50A310DQ41201528-77F8ECBB-D280-452F-89E2-50C1EA53EAA7Q41269070-C0E3A53A-1566-430E-B8B2-2B212B53E747Q41344883-B1332E0A-9A18-4F1C-B9DD-70AE7921DFDBQ41597280-FF70BD72-6657-45E3-A3B3-7BC07C768576Q43606309-10189320-A909-4C97-9012-41485FB840ACQ51470133-2015B9CB-162E-4914-AC58-4175AB75B466
P2860
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effect of tenofovir disoproxil ...... : a nested case-control study.
@en
Effect of tenofovir disoproxil ...... : a nested case-control study.
@nl
type
label
Effect of tenofovir disoproxil ...... : a nested case-control study.
@en
Effect of tenofovir disoproxil ...... : a nested case-control study.
@nl
prefLabel
Effect of tenofovir disoproxil ...... : a nested case-control study.
@en
Effect of tenofovir disoproxil ...... : a nested case-control study.
@nl
P2093
P50
P1433
P1476
Effect of tenofovir disoproxil ...... y: a nested case-control study
@en
P2093
Andrew Riordan
David Dunn
Delane Shingadia
Hermione Lyall
Karina Butler
Katherine L Boyd
P304
P356
10.1097/QAD.0B013E3283333680
P407
P577
2010-02-01T00:00:00Z